发布求助
文献互助 智能选刊 最新文献

Actualites Pharmaceutiques最新文献

筛选
英文 中文
Actualités – livres 新闻 - 图书
IF 0.1
Actualites Pharmaceutiques Pub Date : 2024-09-20 DOI: 10.1016/j.actpha.2024.09.019
{"title":"Actualités – livres","authors":"","doi":"10.1016/j.actpha.2024.09.019","DOIUrl":"10.1016/j.actpha.2024.09.019","url":null,"abstract":"","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":null,"pages":null},"PeriodicalIF":0.1,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142310947","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recrudescence de cas d’infections invasives à méningocoques, vers une vaccination obligatoire 侵袭性脑膜炎球菌病再次爆发，走向强制疫苗接种
IF 0.1
Actualites Pharmaceutiques Pub Date : 2024-09-20 DOI: 10.1016/j.actpha.2024.07.011
{"title":"Recrudescence de cas d’infections invasives à méningocoques, vers une vaccination obligatoire","authors":"","doi":"10.1016/j.actpha.2024.07.011","DOIUrl":"10.1016/j.actpha.2024.07.011","url":null,"abstract":"<div><div>L’infection invasive à méningocoque est mortelle dans 10 % des cas, malgré la mise en place d’une antibiothérapie. Cette dernière doit être initiée le plus rapidement possible et associée à une corticothérapie par dexaméthasone. Les cas contacts doivent suivre également un traitement prophylactique. En France, seule la vaccination contre le méningocoque C est obligatoire chez les nourrissons. Face à l’augmentation des infections dues aux autres sérogroupes, la Haute Autorité de santé a proposé une vaccination obligatoire contre l’ensemble des sérogroupes à l’horizon 2025.</div></div><div><div>Invasive meningococcal infection is fatal in 10% of cases, despite the initiation of antibiotic therapy. Antibiotic therapy should be initiated as soon as possible, and combined with dexamethasone corticosteroid therapy. Contact cases should also be treated prophylactically. In France, only vaccination against meningococcal C is compulsory for infants. In view of the increase in infections caused by other serogroups, the French National Authority for Health has proposed mandatory vaccination against all serogroups by 2025.</div></div>","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":null,"pages":null},"PeriodicalIF":0.1,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142310951","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
La maladie de Crohn, complexe et invalidante 克罗恩病，复杂性和致残性
IF 0.1
Actualites Pharmaceutiques Pub Date : 2024-09-20 DOI: 10.1016/j.actpha.2024.07.012
{"title":"La maladie de Crohn, complexe et invalidante","authors":"","doi":"10.1016/j.actpha.2024.07.012","DOIUrl":"10.1016/j.actpha.2024.07.012","url":null,"abstract":"<div><div>La maladie de Crohn correspond à l’une des deux entités nosologiques qui constituent les maladies inflammatoires chroniques de l’intestin, la seconde étant la rectocolite hémorragique. Sa symptomatologie se caractérise par un état inflammatoire qui évolue par poussées, entrecoupées de périodes de rémission, dont l’intensité et la sévérité croissent avec le temps.</div></div><div><div>Crohn’s disease is one of two nosological entities that make up chronic inflammatory bowel disease, the second being ulcerative colitis. Its symptomatology is characterized by an inflammatory state that evolves in relapses, interspersed with periods of remission, the intensity and severity of which increase over time.</div></div>","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":null,"pages":null},"PeriodicalIF":0.1,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142310952","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prise en charge de la bronchiolite 支气管炎的治疗
IF 0.1
Actualites Pharmaceutiques Pub Date : 2024-09-20 DOI: 10.1016/j.actpha.2024.07.009
{"title":"Prise en charge de la bronchiolite","authors":"","doi":"10.1016/j.actpha.2024.07.009","DOIUrl":"10.1016/j.actpha.2024.07.009","url":null,"abstract":"<div><div>La bronchiolite aiguë du nourrisson est une infection virale. Les professionnels de santé doivent savoir reconnaître les signes de gravité et/ou de vulnérabilité nécessitant l’orientation de l’enfant vers une consultation médicale urgente. Le traitement de la bronchiolite est strictement symptomatique. Il comprend notamment des désobstructions rhinopharyngées régulières au sérum physiologique et un fractionnement de l’alimentation.</div></div><div><div>Acute bronchiolitis in infants is a viral infection. Healthcare professionals must be able to recognize signs of seriousness and/or vulnerability, and refer the child for urgent medical attention. Treatment of bronchiolitis is strictly symptomatic. It includes regular nasopharyngeal decontamination with physiological saline and fractioned feeding.</div></div>","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":null,"pages":null},"PeriodicalIF":0.1,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142310949","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
actualités professionnelles 商业新闻
IF 0.1
Actualites Pharmaceutiques Pub Date : 2024-09-20 DOI: 10.1016/j.actpha.2024.09.017
{"title":"actualités professionnelles","authors":"","doi":"10.1016/j.actpha.2024.09.017","DOIUrl":"10.1016/j.actpha.2024.09.017","url":null,"abstract":"","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":null,"pages":null},"PeriodicalIF":0.1,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142310945","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Épidémiologie et diagnostic des infections à virus respiratoire syncytial 呼吸道合胞病毒感染的流行病学和诊断
IF 0.1
Actualites Pharmaceutiques Pub Date : 2024-09-20 DOI: 10.1016/j.actpha.2024.07.007
{"title":"Épidémiologie et diagnostic des infections à virus respiratoire syncytial","authors":"","doi":"10.1016/j.actpha.2024.07.007","DOIUrl":"10.1016/j.actpha.2024.07.007","url":null,"abstract":"<div><div>Le virus respiratoire syncytial touche l’ensemble de la population, du nouveau-né à l’adulte âgé, et est à l’origine d’épidémies saisonnières de mi-octobre à début février. Il est principalement responsable de la bronchiolite qui touche environ un tiers des nourrissons. Les formes sévères entraînent chaque année des tensions dans les structures sanitaires hospitalières et libérales.</div></div><div><div>Respiratory syncytial virus affects the whole population, from newborns to elderly adults, and causes seasonal epidemics from mid-October to early February. It is mainly responsible for bronchiolitis, which affects around a third of infants. Each year, severe forms of the disease put a strain on hospital and private healthcare facilities.</div></div>","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":null,"pages":null},"PeriodicalIF":0.1,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142310942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Combattre l’hépatite B grâce au dépistage et à la vaccination 通过筛查和疫苗接种防治乙型肝炎
IF 0.1
Actualites Pharmaceutiques Pub Date : 2024-09-20 DOI: 10.1016/j.actpha.2024.07.015
{"title":"Combattre l’hépatite B grâce au dépistage et à la vaccination","authors":"","doi":"10.1016/j.actpha.2024.07.015","DOIUrl":"10.1016/j.actpha.2024.07.015","url":null,"abstract":"","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":null,"pages":null},"PeriodicalIF":0.1,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142310955","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Le pharmacien, un acteur clé dans la lutte contre le virus respiratoire syncytial 药剂师是抗击呼吸道合胞病毒的关键角色
IF 0.1
Actualites Pharmaceutiques Pub Date : 2024-09-20 DOI: 10.1016/j.actpha.2024.07.010
{"title":"Le pharmacien, un acteur clé dans la lutte contre le virus respiratoire syncytial","authors":"","doi":"10.1016/j.actpha.2024.07.010","DOIUrl":"10.1016/j.actpha.2024.07.010","url":null,"abstract":"<div><div>L’infection à virus respiratoire syncytial (VRS) est particulièrement à risque chez les nourrissons et les sujets de 60 ans et plus. Le pharmacien joue un rôle important dans la prévention, l’accompagnement des malades et la pharmacovigilance. Deux stratégies médicamenteuses sont développées pour prévenir l’infection à VRS chez le nourrisson : l’immunoprophylaxie passive par les anticorps monoclonaux et la vaccination des femmes enceintes. La mise à disposition du nirsévimab, anticorps monoclonal, en 2023 a permis de diminuer le nombre d’hospitalisations de nourrissons lors de l’épidémie 2023-2024. Dans le cadre de la campagne 2024-2025, une alternative est proposée, la vaccination de la femme enceinte. La Haute Autorité de santé recommande désormais de vacciner avec Abrysvo® ou Arexvy® les personnes âgées de 75 ans et plus, ainsi que celles de 65 ans et plus présentant des pathologies respiratoires ou cardiaques chroniques.</div></div><div><div>Respiratory syncytial virus (RSV) infection is particularly at risk in infants and people aged 60 and over. Pharmacists play an important role in prevention, patient support and pharmacovigilance. Two drug strategies have been developed to prevent RSV infection in infants: passive immunoprophylaxis with monoclonal antibodies and vaccination of pregnant women. The availability of the monoclonal antibody nirsévimab in 2023 helped reduce the number of infant hospitalizations during the 2023-2024 epidemic. As part of the 2024-2025 campaign, an alternative is proposed: vaccination of pregnant women. The French National Authority for Health now recommends that people aged 75 and over, and those aged 65 and over with chronic respiratory or cardiac pathologies, be vaccinated with Abrysvo® or Arexvy®.</div></div>","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":null,"pages":null},"PeriodicalIF":0.1,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142310950","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vaccination des enfants : accompagner la décision des parents 为儿童接种疫苗：支持家长的决定
IF 0.1
Actualites Pharmaceutiques Pub Date : 2024-09-20 DOI: 10.1016/j.actpha.2024.07.013
{"title":"Vaccination des enfants : accompagner la décision des parents","authors":"","doi":"10.1016/j.actpha.2024.07.013","DOIUrl":"10.1016/j.actpha.2024.07.013","url":null,"abstract":"<div><div>La décision vaccinale est un processus plus ou moins long. Le pharmacien doit comprendre l’hésitation puis s’attacher à appréhender les différents freins qui la composent. Ces derniers sont d’autant plus difficiles à lever que la décision concerne les enfants.</div></div><div><div>The decision to vaccinate is a lengthy process. The pharmacist needs to understand the hesitation, and then work to understand the various obstacles involved. The latter are all the more difficult to overcome when the decision concerns children.</div></div>","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":null,"pages":null},"PeriodicalIF":0.1,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142310953","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Homéostasie phosphocalcique 磷酰平衡
IF 0.1
Actualites Pharmaceutiques Pub Date : 2024-09-20 DOI: 10.1016/j.actpha.2024.07.014
{"title":"Homéostasie phosphocalcique","authors":"","doi":"10.1016/j.actpha.2024.07.014","DOIUrl":"10.1016/j.actpha.2024.07.014","url":null,"abstract":"<div><div>Le calcium intervient dans de nombreuses fonctions cellulaires et physiologiques telles que la minéralisation osseuse, l’excitabilité cellulaire cardiaque et neuronale, ou comme second messager intracellulaire. Ses concentrations plasmatiques doivent être finement régulées. Les mouvements de calcium étant étroitement liés aux phosphates, l’homéostasie phosphocalcique fait intervenir un grand nombre de protagonistes communiquant entre eux principalement par voie endocrinienne.</div></div>","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":null,"pages":null},"PeriodicalIF":0.1,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142310954","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信